{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T04:02:37Z","timestamp":1770436957815,"version":"3.49.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reports"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.pharep.2014.10.009","type":"journal-article","created":{"date-parts":[[2014,10,29]],"date-time":"2014-10-29T22:39:37Z","timestamp":1414622377000},"page":"275-280","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["The effects of valproate and olanzapine on the abnormal behavior of diacylglycerol kinase \u03b2 knockout mice"],"prefix":"10.1007","volume":"67","author":[{"given":"Mitsue","family":"Ishisaka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saori","family":"Tsujii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Mizoguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Tsuruma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masamitsu","family":"Shimazawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideaki","family":"Hara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"issue":"8","key":"10.1016\/j.pharep.2014.10.009_bib0005","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1136\/jmg.36.8.585","article-title":"Genetics of bipolar disorder","volume":"36","author":"Craddock","year":"1999","journal-title":"J Med Genet"},{"issue":"2","key":"10.1016\/j.pharep.2014.10.009_bib0010","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.pnpbp.2003.10.015","article-title":"Perspectives for the development of animal models of bipolar disorder","volume":"28","author":"Machado-Vieira","year":"2004","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"3","key":"10.1016\/j.pharep.2014.10.009_bib0015","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.lfs.2006.01.002","article-title":"Effects of mood stabilizers on hippocampus BDNF levels in an animal model of mania","volume":"79","author":"Frey","year":"2006","journal-title":"Life Sci"},{"issue":"1","key":"10.1016\/j.pharep.2014.10.009_bib0020","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S1734-1140(11)70399-1","article-title":"Magnesium sulfate and sodium valproate block methylphenidate-induced hyperlocomotion, an animal model of mania","volume":"63","author":"Barbosa","year":"2011","journal-title":"Pharmacol Rep"},{"issue":"7","key":"10.1016\/j.pharep.2014.10.009_bib0025","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.pnpbp.2006.04.003","article-title":"Efficacy of olanzapine and haloperidol in an animal model of mania","volume":"30","author":"El-Mallakh","year":"2006","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"5","key":"10.1016\/j.pharep.2014.10.009_bib0030","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1017\/S1461145712001198","article-title":"Chronic valproate attenuates some, but not all, facets of mania-like behaviour in mice","volume":"16","author":"van Enkhuizen","year":"2013","journal-title":"Int J Neuropsychopharmacol"},{"issue":"7474","key":"10.1016\/j.pharep.2014.10.009_bib0035","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/nature12630","article-title":"SHANK3 overexpression causes manic-like behaviour with unique pharmacogenetic properties","volume":"503","author":"Han","year":"2013","journal-title":"Nature"},{"issue":"17","key":"10.1016\/j.pharep.2014.10.009_bib0040","doi-asserted-by":"crossref","first-page":"11447","DOI":"10.1074\/jbc.274.17.11447","article-title":"Mammalian diacylglycerol kinases, a family of lipid kinases with signaling functions","volume":"274","author":"Topham","year":"1999","journal-title":"J Biol Chem"},{"issue":"13","key":"10.1016\/j.pharep.2014.10.009_bib0045","doi-asserted-by":"crossref","first-page":"8347","DOI":"10.1074\/jbc.274.13.8347","article-title":"The role of phosphoinositide 3-kinase lipid products in cell function","volume":"274","author":"Rameh","year":"1999","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.pharep.2014.10.009_bib0050","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1152\/physrev.1997.77.2.303","article-title":"Phospholipase D: enzymology, mechanisms of regulation, and function","volume":"77","author":"Exton","year":"1997","journal-title":"Physiol Rev"},{"issue":"16","key":"10.1016\/j.pharep.2014.10.009_bib0055","doi-asserted-by":"crossref","first-page":"7598","DOI":"10.1073\/pnas.90.16.7598","article-title":"Molecular cloning and expression of a 90-kDa diacylglycerol kinase that predominantly localizes in neurons","volume":"90","author":"Goto","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.pharep.2014.10.009_bib0060","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jbior.2012.03.003","article-title":"Diacylglycerol kinase beta in neurons: functional implications at the synapse and in disease","volume":"52","author":"Hozumi","year":"2012","journal-title":"Adv Biol Regul"},{"key":"10.1016\/j.pharep.2014.10.009_bib0065","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/1471-2202-10-99","article-title":"Diacylglycerol kinase beta promotes dendritic outgrowth and spine maturation in developing hippocampal neurons","volume":"10","author":"Hozumi","year":"2009","journal-title":"BMC Neurosci"},{"issue":"12","key":"10.1016\/j.pharep.2014.10.009_bib0070","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1111\/j.1460-9568.2008.06547.x","article-title":"Diacylglycerol kinase beta accumulates on the perisynaptic site of medium spiny neurons in the striatum","volume":"28","author":"Hozumi","year":"2008","journal-title":"Eur J Neurosci"},{"issue":"7","key":"10.1016\/j.pharep.2014.10.009_bib0075","doi-asserted-by":"crossref","first-page":"4790","DOI":"10.1074\/jbc.M110249200","article-title":"Molecular cloning and characterization of the human diacylglycerol kinase beta (DGKbeta) gene: alternative splicing generates DGKbeta isotypes with different properties","volume":"277","author":"Caricasole","year":"2002","journal-title":"J Biol Chem"},{"issue":"7","key":"10.1016\/j.pharep.2014.10.009_bib0080","doi-asserted-by":"crossref","first-page":"e11602","DOI":"10.1371\/journal.pone.0011602","article-title":"Essential role of neuron-enriched diacylglycerol kinase (DGK), DGKbeta in neurite spine formation, contributing to cognitive function","volume":"5","author":"Shirai","year":"2010","journal-title":"PLoS ONE"},{"issue":"10","key":"10.1016\/j.pharep.2014.10.009_bib0085","doi-asserted-by":"crossref","first-page":"e13447","DOI":"10.1371\/journal.pone.0013447","article-title":"Diacylglycerol kinase beta knockout mice exhibit lithium-sensitive behavioral abnormalities","volume":"5","author":"Kakefuda","year":"2010","journal-title":"PLoS ONE"},{"issue":"5","key":"10.1016\/j.pharep.2014.10.009_bib0090","doi-asserted-by":"crossref","first-page":"e37058","DOI":"10.1371\/journal.pone.0037058","article-title":"Diacylglycerol kinase beta knockout mice exhibit attention-deficit behavior and an abnormal response on methylphenidate-induced hyperactivity","volume":"7","author":"Ishisaka","year":"2012","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.pharep.2014.10.009_bib0095","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1254\/jphs.13R07CR","article-title":"The roles of diacylglycerol kinases in the central nervous system: review of genetic studies in mice","volume":"124","author":"Ishisaka","year":"2014","journal-title":"J Pharmacol Sci"},{"issue":"10","key":"10.1016\/j.pharep.2014.10.009_bib0100","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1038\/npp.2011.98","article-title":"Cross-disorder analysis of bipolar risk genes: further evidence of DGKH as a risk gene for bipolar disorder, but also unipolar depression and adult ADHD","volume":"36","author":"Weber","year":"2011","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.pharep.2014.10.009_bib0105","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/sj.mp.4002012","article-title":"A genome-wide association study implicates diacylglycerol kinase eta (DGKH) and several other genes in the etiology of bipolar disorder","volume":"13","author":"Baum","year":"2008","journal-title":"Mol Psychiatry"},{"issue":"8","key":"10.1016\/j.pharep.2014.10.009_bib0110","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1017\/S1461145710000593","article-title":"Increased gene expression of diacylglycerol kinase eta in bipolar disorder","volume":"13","author":"Moya","year":"2010","journal-title":"Int J Neuropsychopharmacol"},{"issue":"8","key":"10.1016\/j.pharep.2014.10.009_bib0115","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1517\/17460441.2013.804057","article-title":"Novel routes to bipolar disorder drug discovery","volume":"8","author":"Hoertel","year":"2013","journal-title":"Expert Opin Drug Discov"},{"issue":"2","key":"10.1016\/j.pharep.2014.10.009_bib0120","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s12035-013-8566-8","article-title":"Fenproporex increases locomotor activity and alters energy metabolism, and mood stabilizers reverse these changes: a proposal for a new animal model of mania","volume":"49","author":"Rezin","year":"2014","journal-title":"Mol Neurobiol"},{"issue":"1","key":"10.1016\/j.pharep.2014.10.009_bib0125","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1590\/1516-4446-2013-1094","article-title":"Histone deacetylase activity and brain-derived neurotrophic factor (BDNF) levels in a pharmacological model of mania","volume":"36","author":"Stertz","year":"2013","journal-title":"Rev Bras Psiquiatr"},{"issue":"3\u20134","key":"10.1016\/j.pharep.2014.10.009_bib0130","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.physbeh.2011.03.005","article-title":"Behavioral and pharmacological assessment of a potential new mouse model for mania","volume":"103","author":"Scotti","year":"2011","journal-title":"Physiol Behav"},{"issue":"1","key":"10.1016\/j.pharep.2014.10.009_bib0135","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.brainres.2006.04.081","article-title":"Effects of divalproex and atypical antipsychotic drugs on dopamine and acetylcholine efflux in rat hippocampus and prefrontal cortex","volume":"1099","author":"Huang","year":"2006","journal-title":"Brain Res"},{"issue":"13","key":"10.1016\/j.pharep.2014.10.009_bib0140","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1038\/npp.2012.139","article-title":"Clozapine-induced locomotor suppression is mediated by 5-HT2A receptors in the forebrain","volume":"37","author":"McOmish","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharep.2014.10.009_bib0145","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.neuroscience.2011.09.056","article-title":"The effects of neuropsychiatric drugs on glycogen synthase kinase-3 signaling","volume":"199","author":"Sutton","year":"2011","journal-title":"Neuroscience"},{"issue":"3","key":"10.1016\/j.pharep.2014.10.009_bib0150","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s00213-009-1551-2","article-title":"Early effects of mood stabilizers on the Akt\/GSK-3beta signaling pathway and on cell survival and proliferation","volume":"205","author":"Aubry","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"issue":"2","key":"10.1016\/j.pharep.2014.10.009_bib0155","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1034\/j.1399-5618.2002.40201.x","article-title":"Glycogen synthase kinase-3beta, mood stabilizers, and neuroprotection","volume":"4","author":"Li","year":"2002","journal-title":"Bipolar Disord"},{"issue":"9","key":"10.1016\/j.pharep.2014.10.009_bib0160","doi-asserted-by":"crossref","first-page":"3756","DOI":"10.1172\/JCI45194","article-title":"Glycogen synthase kinase-3 is essential for beta-arrestin-2 complex formation and lithium-sensitive behaviors in mice","volume":"121","author":"O\u2019Brien","year":"2011","journal-title":"J Clin Invest"},{"issue":"14","key":"10.1016\/j.pharep.2014.10.009_bib0165","doi-asserted-by":"crossref","first-page":"5099","DOI":"10.1073\/pnas.0307921101","article-title":"Lithium antagonizes dopamine-dependent behaviors mediated by an AKT\/glycogen synthase kinase 3 signaling cascade","volume":"101","author":"Beaulieu","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.pharep.2014.10.009_bib0170","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1111\/j.1471-4159.2005.03637.x","article-title":"Alzheimer-like changes in protein kinase B and glycogen synthase kinase-3 in rat frontal cortex and hippocampus after damage to the insulin signalling pathway","volume":"96","author":"Salkovic-Petrisic","year":"2006","journal-title":"J Neurochem"},{"issue":"3","key":"10.1016\/j.pharep.2014.10.009_bib0175","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1124\/jpet.105.090845","article-title":"An investigation of the efficacy of mood stabilizers in rodent models of prepulse inhibition","volume":"315","author":"Ong","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharep.2014.10.009_bib0180","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/srep00546","article-title":"Overstimulation of newborn mice leads to behavioral differences and deficits in cognitive performance","volume":"2","author":"Christakis","year":"2012","journal-title":"Sci Rep"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114014003211?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114014003211?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T20:35:47Z","timestamp":1752611747000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1016\/j.pharep.2014.10.009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S1734114014003211"],"URL":"https:\/\/doi.org\/10.1016\/j.pharep.2014.10.009","relation":{},"ISSN":["1734-1140"],"issn-type":[{"value":"1734-1140","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effects of valproate and olanzapine on the abnormal behavior of diacylglycerol kinase \u03b2 knockout mice","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharep.2014.10.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier Urban & Partner Sp. z o.o. All rights reserved.","name":"copyright","label":"Copyright"}]}}